Stockreport

Suvannavejh: The obesity space has become a major focus for investors [CNBC]

Mizuho Financial Group, Inc. Sponosred ADR (Japan)  (MFG) 
US:NYSE Investor Relations: mizuho-fg.com/investors/index.html
PDF Graig Suvannavejh, Biotech and Biopharma Analyst at Mizuho Securities, says Oral GLP-1 obesity drugs and looming patent cliffs will drive big pharma into biotech M&A, es [Read more]